Inovio Pharmaceuticals Income Statement (2010-2025) | INO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)	0.37M	0.27M	0.29M	0.84M	0.20M	0.78M	9.15M	0.12M	0.11M	0.23M	0.39M	0.10M		0.10M		0.12M	0.07M
Operating items
Research & Development (Quarter)	39.04M	70.81M	47.09M	92.30M	55.98M	56.46M	33.09M	42.12M	30.18M	23.74M	15.50M	17.25M	20.91M	23.09M	18.73M	12.89M	16.09M	14.52M	13.33M	10.26M
Selling, General & Administrative (Quarter)	13.88M	12.67M	13.16M	14.05M	15.95M	48.46M	11.82M	13.95M	13.89M	13.52M	9.93M	10.24M	10.57M	10.21M	8.61M	7.60M	9.02M	8.56M	7.88M	7.22M
Other Operating Expenses (Quarter)											10.51M
Operating Expenses (Quarter)	52.93M	83.47M	60.24M	106.35M	71.93M	104.92M	44.91M	56.07M	44.07M	37.27M	35.94M	27.50M	31.48M	33.30M	27.35M	20.49M	25.12M	23.08M	21.21M	17.48M
Operating Income (Quarter)	-52.55M	-83.20M	-59.95M	-105.51M	-71.73M	-104.14M	-35.76M	-55.95M	-43.95M	-37.04M	-35.55M	-27.39M	-31.48M	-33.20M	-27.35M	-20.37M	-25.05M	-23.08M	-21.21M	-17.48M
EBIT (Quarter)	-52.55M	-83.20M	-59.95M	-105.51M	-71.73M	-104.14M	-35.76M	-55.95M	-43.95M	-37.04M	-35.55M	-27.39M	-31.48M	-33.20M	-27.35M	-20.37M	-25.05M	-23.08M	-21.21M	-17.48M
Non-operating items
Interest & Investment Income (Quarter)											1.94M	1.82M	1.50M	1.31M	1.11M	0.85M	0.81M	0.61M	0.55M	0.45M
Other Non Operating Income (Quarter)	0.01M	0.19M	-0.03M	0.18M	-0.15M	-0.00M	-0.94M	-2.76M	-2.43M	-1.43M	0.00M	-0.86M	-0.68M	0.01M	-0.58M	-1.91M	-482.00	-0.70M	-1.94M	88.00
Non Operating Income (Quarter)	0.01M	0.19M	-0.03M	0.18M	-0.15M	-0.00M	-0.94M	-2.76M	-2.43M	-1.43M	0.00M	-0.86M	-0.68M	0.01M	-0.58M	-1.91M	-482.00	-0.70M	-1.94M	88.00
Net income details
EBT (Quarter)	-53.97M	-82.14M	-60.17M	-106.95M	-76.91M	-108.50M	-37.78M	-54.46M	-40.65M	-35.53M	-33.93M	-25.00M	-30.16M	-31.89M	-26.24M	-19.52M	-24.24M	-22.47M	-20.66M	-17.03M
Tax Provisions (Quarter)
Profit After Tax (Quarter)	-54.40M	-82.14M	-60.17M	-106.95M	-79.07M	-108.50M	-37.78M	-54.46M	-40.65M	-35.53M	-33.93M	-25.00M	-30.47M	-32.24M	-25.17M	-19.38M	-19.69M	-23.52M	-45.50M	3.76M
Equity Income (Quarter)	-0.82M			-2.79M	-2.20M	-3.97M		8.48M	3.22M	0.92M	-0.22M	1.95M	0.50M	-0.02M	1.30M	0.30M	0.14M	0.76M	0.20M	0.01M
Net Income - Minority (Quarter)
Income from Non-Controlling Interests (Quarter)
Income from Continuing Operations (Quarter)	-53.97M	-82.14M	-60.17M	-106.95M	-76.91M	-108.50M	-37.78M	-54.46M	-40.65M	-35.53M	-33.93M	-25.00M	-30.16M	-31.89M	-26.24M	-19.52M	-24.24M	-22.47M	-20.66M	-17.03M
Consolidated Net Income (Quarter)	-53.97M	-82.14M	-60.17M	-106.95M	-76.91M	-108.50M	-37.78M	-54.46M	-40.65M	-35.53M	-33.93M	-25.00M	-30.16M	-31.89M	-26.24M	-19.52M	-24.24M	-22.47M	-20.66M	-17.03M
Income towards Parent Company (Quarter)	-53.97M	-82.14M	-60.17M	-106.95M	-76.91M	-108.50M	-37.78M	-54.46M	-40.65M	-35.53M	-33.93M	-25.00M	-30.16M	-31.89M	-26.24M	-19.52M	-24.24M	-22.47M	-20.66M	-17.03M
Net Income towards Common Stockholders (Quarter)	-53.97M	-82.14M	-60.17M	-106.95M	-76.91M	-108.50M	-37.78M	-54.46M	-40.65M	-35.53M	-33.93M	-25.00M	-30.16M	-31.89M	-26.24M	-19.52M	-24.24M	-22.47M	-20.66M	-17.03M
Additional items
EPS (Basic) (Quarter)	-0.27	-0.39	-0.29	-16.50	-0.36	-0.46	-0.15	-13.11	-1.89	-1.61	-1.52	-1.08	-1.31	-1.19	-0.89	-0.60	-0.51	-0.61	-0.87	0.31
EPS (Weighted Average and Diluted) (Quarter)	-0.27	-0.39	-0.29	-16.50	-0.36	-0.46	-0.15	-13.11	-1.89	-1.61	-1.52	-1.08	-1.31	-1.19	-0.89	-0.60	-0.51	-0.61	-0.87	0.31
Shares Outstanding (Weighted Average) (Quarter)	202.41M	209.56M	207.46M	17.40M	218.94M	227.15M	234.63M	19.89M	21.54M	22.03M	22.39M	22.17M	23.29M	25.24M	26.22M	27.16M	38.61M	38.83M	52.17M	46.89M
Shares Outstanding (Diluted Average) (Quarter)	202.41M	209.56M	210.30M	17.40M	218.94M	227.15M	234.63M	19.89M	21.54M	21.78M	22.39M	22.17M	23.29M	27.20M	26.22M	27.16M	38.61M	38.72M	41.84M	46.89M
EBITDA (Quarter)	-52.55M	-83.20M	-59.95M	-105.51M	-71.73M	-104.14M	-35.76M	-55.95M	-43.95M	-37.04M	-35.55M	-27.39M	-31.48M	-33.20M	-27.35M	-20.37M	-25.05M	-23.08M	-21.21M	-17.48M
Interest Expenses (Quarter)	0.51M	0.47M	0.48M	0.48M	0.31M	0.31M	0.31M	0.31M	0.31M	0.31M	0.31M	0.28M	0.18M
Shares Outstanding (Quarter)	209.33M	9.00	210.36M	18.12M	226.51M	9.00	249.49M	21.09M	9.12M	268.07M	22.48M	22.79M	23.37M	9.00	26.05M	36.10M	36.67M	36.72M	53.57M	69.00M
Tax Rate (Quarter)

Research Tools

Inovio Pharmaceuticals Income Statement (2010-2025) | INO

Create an account

Sign In

Reset Password